Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 120685-11-2
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of midostaurin during breastfeeding. Because midostaurin and its active metabolites are 99.8% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during midostaurin therapy and for 4 months after the last dose. Avoiding breastfeeding is particularly important when midostaurin is given with other cancer chemotherapy agents.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Midostaurin
CAS Registry Number
120685-11-2
Drug Class
Breast Feeding
Milk, Human
Antineoplastic Agents
Enzyme Inhibitors
Protein Kinase Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Effects of inhibitors for intracellular signal transduction systems on the inward current produced by GABA in a snail neuron.[Gen Pharmacol. 1998]Effects of inhibitors for intracellular signal transduction systems on the inward current produced by GABA in a snail neuron.Zhang W, Han XY, Wong SM, Takeuchi H. Gen Pharmacol. 1998 Feb; 30(2):221-5.
- Review Telithromycin.[Drugs and Lactation Database (...]Review Telithromycin.. Drugs and Lactation Database (LactMed®). 2006
- Isolation and antifungal and antioomycete activities of staurosporine from Streptomyces roseoflavus strain LS-A24.[J Agric Food Chem. 2006]Isolation and antifungal and antioomycete activities of staurosporine from Streptomyces roseoflavus strain LS-A24.Park HJ, Lee JY, Hwang IS, Yun BS, Kim BS, Hwang BK. J Agric Food Chem. 2006 Apr 19; 54(8):3041-6.
- Review Axitinib.[Drugs and Lactation Database (...]Review Axitinib.. Drugs and Lactation Database (LactMed®). 2006
- Review Paclitaxel.[Drugs and Lactation Database (...]Review Paclitaxel.. Drugs and Lactation Database (LactMed®). 2006
- Midostaurin - Drugs and Lactation Database (LactMed®)Midostaurin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...